Accra: The Africa Centres for Disease Control and Prevention (Africa CDC) has announced the launch of the African Manufacturing Market Intelligence and Network Analysis (AMMINA) platform. This data-driven initiative is designed to enhance the health products manufacturing ecosystem across Africa and promote regional health sovereignty.
According to News Agency of Nigeria, the launch took place during the African Healthcare Manufacturing Trade Exhibition and Conference (AHMTEC) in Accra, Ghana. The initiative underscores Africa CDC’s commitment to advancing local production, innovation, and investment in the continent’s health sector. AMMINA was developed under the custodianship of Africa CDC, with initial curation by the Bill and Melinda Gates Foundation, to provide comprehensive insights into Africa’s health manufacturing landscape, including data on manufacturers, production capacities, and market dynamics.
Dr. Jean Kaseya, Director-General of Africa CDC, noted that the platform is a significant step toward empowering Africa’s health sovereignty through evidence-based decision-making and strategic collaboration. “We are pleased to launch this landmark initiative. AMMINA represents a bold step towards making high-quality, reliable, and accessible data available to our member states and partners,” Kaseya stated. He emphasized that Africa CDC is committed to ensuring AMMINA becomes a trusted continental resource for advancing health products manufacturing, investment, and policy decision-making.
In its initial phase, AMMINA maps data from over 700 manufacturers and 2,500 health products across 18 African Union member states. Africa CDC, in collaboration with its partners, aims to expand this coverage to all 55 AU member states, positioning the platform as a continental public good under the African Union’s framework. The platform is expected to catalyze intra-African trade, attract investment, and foster industrial growth in health products manufacturing, which are key drivers for reducing dependency on imported medical products and securing Africa’s health future.
NAN reports that Africa’s health manufacturing sector is undergoing transformation, driven by efforts toward self-reliance, innovation, and regional collaboration. Countries like Morocco and Rwanda have advanced manufacturing facilities, supported by initiatives like the African Vaccine Manufacturing Accelerator (AVMA), which aims to meet 60% of the continent’s vaccine needs by 2040. Despite progress, the sector faces challenges, including limited end-to-end manufacturing, supply chain disruptions, energy constraints, and skills shortages.
Africa CDC’s AMMINA platform now provides actionable data to assist member states, investors, and partners in making informed decisions. Key initiatives include building Regional Capability and Capacity Networks (RCCNs) to develop workforce skills and enhance research, addressing gaps in human resources. Continued investment, infrastructure development, and regional collaboration are deemed critical to achieving Africa’s goal of health sovereignty.